MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Incompatible

Aripiprazole 5mg tablets (Macleods Pharma UK Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 5mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 5mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 5mg tablets (Medical Valley Invest AB)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 5mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 5mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 5mg tablets (Medihealth (Northern) Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 5mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 5mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 5mg tablets (Milpharm Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 5mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 5mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 5mg tablets (Sandoz Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 5mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 5mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 5mg tablets (Sigma Pharmaceuticals Plc)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 5mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 5mg tablets (Aurobindo Pharma - Milpharm Ltd).

No Stability Information

Armour Thyroid 120mg (2 grains) tablets (Imported (United States))

Explore other Levothyroxine + Liothyronine formulations Explore other Levothyroxine sodium 76microgram / Liothyronine 18microgram tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Armour Thyroid 15mg (quarter grain) tablets (Imported (United States))

Explore other Levothyroxine + Liothyronine formulations Explore other Levothyroxine sodium 9.5microgram / Liothyronine 2.25microgram tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Armour Thyroid 180mg (3 grains) tablets (Imported (United States))

Explore other Levothyroxine + Liothyronine formulations Explore other Levothyroxine sodium 114microgram / Liothyronine 27microgram tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Armour Thyroid 30mg (half grain) tablets (Imported (United States))

Explore other Levothyroxine + Liothyronine formulations Explore other Levothyroxine sodium 19microgram / Liothyronine 4.5microgram tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Armour Thyroid 60mg (1 grain) tablets (Imported (United States))

Explore other Levothyroxine + Liothyronine formulations Explore other Levothyroxine sodium 38microgram / Liothyronine 9microgram tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Armour Thyroid 90mg (1 and a half grains) tablets (Imported (United States))

Explore other Levothyroxine + Liothyronine formulations Explore other Levothyroxine sodium 57microgram / Liothyronine 13.5microgram tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Arnica montana 30c homeopathic tablets (Ainsworths (London) Ltd)

Explore other Homeopathic arnica montana formulations Explore other Arnica montana 30c homeopathic tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Arnica montana 30c homeopathic tablets (Weleda (UK) Ltd)

Explore other Homeopathic arnica montana formulations Explore other Arnica montana 30c homeopathic tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Arnica montana 6c homeopathic tablets (Special Order)

Explore other Homeopathic arnica montana formulations Explore other Arnica montana 6c homeopathic tablets suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.